Updated overall survival (OS) analysis for ProCAID: A randomized, double blind, placebo-controlled phase II trial of capivasertib with docetaxel versus docetaxel alone in metastatic castration resistant prostate cancer (mCRPC).
Capivasertib;Docetaxel;Docetaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updated overall survival (OS) analysis for ProCAID: A randomized, double blind, placebo-controlled phase II trial of capivasertib with docetaxel versus docetaxel alone in metastatic castration resistant prostate cancer (mCRPC). ### Output: Capivasertib;Docetaxel;Docetaxel